Vivos Therapeutics Inc.

NASDAQ: VVOS · Real-Time Price · USD
2.48
0.19 (8.30%)
At close: May 29, 2025, 2:40 PM

Vivos Therapeutics Statistics

Share Statistics

Vivos Therapeutics has 5.89M shares outstanding. The number of shares has increased by 73.39% in one year.

Shares Outstanding 5.89M
Shares Change (YoY) 73.39%
Shares Change (QoQ) 21.8%
Owned by Institutions (%) 0.33%
Shares Floating n/a
Failed to Deliver (FTD) Shares 991
FTD / Avg. Volume 1.03%

Short Selling Information

The latest short interest is 259.4K, so 4.4% of the outstanding shares have been sold short.

Short Interest 259.4K
Short % of Shares Out 4.4%
Short % of Float 4.89%
Short Ratio (days to cover) 3.05

Valuation Ratios

The PE ratio is -1.93 and the forward PE ratio is -2.45. Vivos Therapeutics's PEG ratio is 0.02.

PE Ratio -1.93
Forward PE -2.45
PS Ratio 1.43
Forward PS 0.7
PB Ratio 2.71
P/FCF Ratio -1.62
PEG Ratio 0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Vivos Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.5, with a Debt / Equity ratio of 0.19.

Current Ratio 1.5
Quick Ratio 1.5
Debt / Equity 0.19
Debt / EBITDA -0.14
Debt / FCF -0.11
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $137,899.08
Profits Per Employee $-102,165.14
Employee Count 109
Asset Turnover 0.98
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 16.84% in the last 52 weeks. The beta is 7.27, so Vivos Therapeutics's price volatility has been higher than the market average.

Beta 7.27
52-Week Price Change 16.84%
50-Day Moving Average 2.69
200-Day Moving Average 3.25
Relative Strength Index (RSI) 41.01
Average Volume (20 Days) 96,430

Income Statement

In the last 12 months, Vivos Therapeutics had revenue of 15.03M and earned -11.14M in profits. Earnings per share was -1.68.

Revenue 15.03M
Gross Profit 9.02M
Operating Income -11.17M
Net Income -11.14M
EBITDA -10.55M
EBIT -11.17M
Earnings Per Share (EPS) -1.68
Full Income Statement

Balance Sheet

The company has 6.26M in cash and 1.51M in debt, giving a net cash position of 4.75M.

Cash & Cash Equivalents 6.26M
Total Debt 1.51M
Net Cash 4.75M
Retained Earnings -104.19M
Total Assets 11.28M
Working Capital -1.09M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.69M and capital expenditures -568K, giving a free cash flow of -13.26M.

Operating Cash Flow -12.69M
Capital Expenditures -568K
Free Cash Flow -13.26M
FCF Per Share -2.64
Full Cash Flow Statement

Margins

Gross margin is 60%, with operating and profit margins of -74.32% and -74.09%.

Gross Margin 60%
Operating Margin -74.32%
Pretax Margin -74.09%
Profit Margin -74.09%
EBITDA Margin -70.22%
EBIT Margin -74.32%
FCF Margin -88.21%

Dividends & Yields

VVOS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for VVOS is $6.1, which is 166.4% higher than the current price. The consensus rating is "Buy".

Price Target $6.1
Price Target Difference 166.4%
Analyst Consensus Buy
Analyst Count 2
Stock Forecasts

Stock Splits

The last stock split was on Oct 27, 2023. It was a backward split with a ratio of 1:25.

Last Split Date Oct 27, 2023
Split Type backward
Split Ratio 1:25

Scores

Altman Z-Score -13.91
Piotroski F-Score 1